Work

Abstract CT128: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients (pts) with HER2+ early-stage breast cancer (eBC): the CONTROL trial

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2017-ct128

Authors: Emad Ibrahim, Debu Tripathy, Mary Wilkinson, Sara Hurvitz, Nicholas Iannotti, Andrew Kellum, Yvonne Manalo, Serena Wong, Vincent Hansen, Ricardo Alvarez, Arlene Chan, Ira Gore, DiSean Kendall, James Wade, Elizabeth Olek, Daniel Hunt, Pearl Fang, Azita Ebtahaj, Carlos H. Barcenas

Institutions: The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, North Mississippi Medical Center, Rutgers Cancer Institute, Southeastern Health, Hollywood Private Hospital, Utah Cancer Specialists, Cancer Care Specialists of Illinois, Decatur Memorial Hospital, Puma Biotechnology (United States)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2741016607

Cites:

Cited by: 20

Related to: 10